Drug Interaction Report

Apixaban and Abiraterone Acetate: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Abiraterone Acetate

Abirtega Yonsa Zytiga
+

Apixaban

Eliquis Eliquis®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 289 documented Apixaban interactions, 252 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Abiraterone may raise apixaban levels and bleeding risk, so this combination is best avoided; check with your doctor or pharmacist before making any changes, and watch for signs of bleeding.

Here's what's going on. Apixaban (Eliquis) is a blood thinner. Abiraterone can slow down a natural "pump" in your body that helps clear apixaban out. When that pump is blocked, more apixaban can build up in your blood, which may raise your risk of bleeding, things like easy bruising, nosebleeds, or bleeding that is hard to stop.

I want to be clear that this concern comes from how these drugs are expected to behave, not from strong studies, so it is more of a caution than a proven problem. Please don't stop either medicine on your own. Talk with your doctor or pharmacist. They can decide the safest plan and keep a close eye on you.

Mechanism: Abiraterone is a potential P-glycoprotein (P-gp) inhibitor; apixaban is a P-gp substrate. Inhibition of P-gp-mediated efflux may reduce apixaban clearance and increase its systemic exposure (AUC/Cmax), raising bleeding risk. Neither agent requires activation, so this is a straightforward exposure increase.

  • Direction: increased apixaban effect (bleeding risk)
  • Evidence: theoretical; magnitude not quantified
  • Onset: unspecified
  • Severity: major; guidance on file is to avoid coadministration

Management: Avoid the combination where feasible. If used together, monitor closely for signs/symptoms of bleeding; dosing should be individualized by the care team. Consider an alternative anticoagulant if clinically appropriate.

Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased apixaban exposure

Interaction Deep Dive

Taking apixaban (a substrate of P-gp) together with abiraterone (a possible P-gp inhibitor) can raise apixaban concentrations and heighten the likelihood of bleeding, so the two agents should not be given together1.

Why it happens (mechanism)

Inhibition of P-gp-mediated efflux transport of apixaban

How to manage this interaction

Keep taking both medicines as prescribed unless your care team tells you otherwise. The documented advice is that this combination is generally best avoided, so this is worth a conversation.

  • Ask your prescriber or pharmacist whether these two should be used together or whether a different option is safer for you.
  • If you do stay on both, your team may watch you more closely for bleeding, and your dose may need to be adjusted and individualized.
  • Report any unusual bruising, nosebleeds, blood in urine or stool, black stools, or bleeding that won't stop.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Apixaban and Abiraterone Acetate together?

Abiraterone may raise apixaban levels and bleeding risk, so this combination is best avoided; check with your doctor or pharmacist before making any changes, and watch for signs of bleeding. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Apixaban and Abiraterone Acetate interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Apixaban and Abiraterone Acetate interaction managed?

Keep taking both medicines as prescribed unless your care team tells you otherwise. The documented advice is that this combination is generally best avoided, so this is worth a conversation. Ask your prescriber or pharmacist whether these two should be used together or whether a different option is safer for you. If you do stay on both, your team may watch you more closely for bleeding, and your d… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Apixaban or Abiraterone Acetate need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Steffel J, Collins R, Antz M, et al: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021; 23(10):1612-1676.
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.